Huy Dinh, PhD

Research Interest

Cancer is a heterogeneous disease that complicates its study and, therefore, treatment. Immunotherapy has revolutionized cancer treatment, but many patients still are faced with little or no clinical benefit with the same treatment. Recent high-dimensional technologies have allowed us the ability to understand the tumor ecosystem and its impact on treatment response. We are motivated by the questions of how the tumor microenvironment changes upon cancer progress before and after treatment, as well as comparative immunology research between inflammation and cancers.
We are working at the interface between immune cell signaling and molecular pharmacology to identify immunotherapeutic targets and understand their mechanisms of action.